PureHealth Q1 2026 Earnings Report
Analysis based on 12 articles · First reported May 01, 2026 · Last updated May 01, 2026
PureHealth's strong Q1 2026 results, driven by international expansion and resilient performance, are likely to positively impact investor confidence in the company and the broader healthcare and insurance sectors it operates in. The growth in its international portfolio, particularly with Circle Health Group and Saber Healthcare Group, signals successful diversification and potential for sustained future growth, while regulatory impacts in the United Arab Emirates highlight potential domestic challenges.
PureHealth, the largest healthcare group in the Middle East, announced its Q1 2026 financial results, reporting a 10% year-on-year revenue increase to USD 2.0 billion and a 5% EBITDA growth to USD 323 million. Net profit reached USD 113 million, despite some impact from the Unified Purchasing Program (UPP) regulatory developments in the United Arab Emirates. The growth was primarily driven by the strong performance of PureHealth's international Care (healthcare) portfolio, including Circle Health Group in the UK and Saber Healthcare Group in Greece and Cyprus, and its Cover (insurance) vertical. Key strategic updates include Circle Health Group's adoption of Intuitive Surgical's Da Vinci 5 robotic system and Saber Healthcare Group's acquisition of EVANGELISMOS Hospital in Cyprus. PureHealth remains focused on continued international expansion, capacity investment, and digital transformation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard